135 related articles for article (PubMed ID: 25363635)
1. Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.
Joste NE; Ronnett BM; Hunt WC; Pearse A; Langsfeld E; Leete T; Jaramillo M; Stoler MH; Castle PE; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):230-40. PubMed ID: 25363635
[TBL] [Abstract][Full Text] [Related]
2. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
[TBL] [Abstract][Full Text] [Related]
3. The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province.
Yuanyue L; Baloch Z; Yasmeen N; Tao Y; Xiaomei W; Xueshan X
J Infect Public Health; 2018; 11(1):105-110. PubMed ID: 28697900
[TBL] [Abstract][Full Text] [Related]
4. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.
Joura EA; Ault KA; Bosch FX; Brown D; Cuzick J; Ferris D; Garland SM; Giuliano AR; Hernandez-Avila M; Huh W; Iversen OE; Kjaer SK; Luna J; Miller D; Monsonego J; Munoz N; Myers E; Paavonen J; Pitisuttithum P; Steben M; Wheeler CM; Perez G; Saah A; Luxembourg A; Sings HL; Velicer C
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1997-2008. PubMed ID: 25274978
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
6. Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis.
Palmer M; Katanoda K; Saito E; Acuti Martellucci C; Tanaka S; Ikeda S; Sakamoto H; Machelek D; Ml Brotherton J; Hocking JS
Vaccine; 2022 Sep; 40(41):5971-5996. PubMed ID: 36085257
[TBL] [Abstract][Full Text] [Related]
7. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
[TBL] [Abstract][Full Text] [Related]
8. HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.
Hammer A; Mejlgaard E; Gravitt P; Høgdall E; Christiansen P; Steiniche T; Blaakaer J
Acta Obstet Gynecol Scand; 2015 Nov; 94(11):1262-8. PubMed ID: 26300424
[TBL] [Abstract][Full Text] [Related]
9. Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia.
Adcock R; Cuzick J; Hunt WC; McDonald RM; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1816-1824. PubMed ID: 31488417
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer.
Wheeler CM; Hunt WC; Schiffman M; Castle PE;
J Infect Dis; 2006 Nov; 194(9):1291-9. PubMed ID: 17041856
[TBL] [Abstract][Full Text] [Related]
11. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.
Benard VB; Castle PE; Jenison SA; Hunt WC; Kim JJ; Cuzick J; Lee JH; Du R; Robertson M; Norville S; Wheeler CM;
JAMA Oncol; 2017 Jun; 3(6):833-837. PubMed ID: 27685805
[TBL] [Abstract][Full Text] [Related]
12. The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3.
Litjens RJ; Van de Vijver KK; Hopman AH; Ummelen MI; Speel EJ; Sastrowijoto SH; Van Gorp T; Slangen BF; Kruitwagen RF; Krüse AJ
Hum Pathol; 2014 Feb; 45(2):221-6. PubMed ID: 24439220
[TBL] [Abstract][Full Text] [Related]
13. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
Herweijer E; Sundström K; Ploner A; Uhnoo I; Sparén P; Arnheim-Dahlström L
Int J Cancer; 2016 Jun; 138(12):2867-74. PubMed ID: 26856527
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
15. Trend of human papillomavirus genotypes in cervical neoplasia observed in a newly developing township in Yangon, Myanmar.
Mu Mu Shwe ; Kyi Kyi Nyunt ; Okada S; Harano T; Hlaing Myat Thu ; Hla Myat Mo Mo ; Mo Mo Win ; Khin Khin Oo ; Khin Thet Wai ; Khin Saw Aye ; Myo Khin
Acta Med Okayama; 2015; 69(1):51-8. PubMed ID: 25703171
[TBL] [Abstract][Full Text] [Related]
16. Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynaecol Obstet; 2017 Oct; 139(1):90-94. PubMed ID: 28632949
[TBL] [Abstract][Full Text] [Related]
17. Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
Correa RM; Baena A; Valls J; Colucci MC; Mendoza L; Rol M; Wiesner C; Ferrera A; Fellner MD; González JV; Basiletti JA; Mongelos P; Rodriguez de la Peña M; Saino A; Kasamatsu E; Velarde C; Macavilca N; Martinez S; Venegas G; Calderón A; Rodriguez G; Barrios H; Herrero R; Almonte M; Picconi MA;
PLoS One; 2022; 17(7):e0272205. PubMed ID: 35905130
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas.
Catarino R; Vassilakos P; Jinoro J; Broquet C; Benski AC; Meyer-Hamme U; Petignat P
Cancer Epidemiol; 2016 Jun; 42():159-66. PubMed ID: 27161432
[TBL] [Abstract][Full Text] [Related]
19. Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes.
Montealegre JR; Varier I; Bracamontes CG; Dillon LM; Guillaud M; Sikora AG; Follen M; Adler-Storthz K; Scheurer ME
Ethn Health; 2019 Oct; 24(7):804-815. PubMed ID: 28870103
[No Abstract] [Full Text] [Related]
20. Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions.
Payano VJH; Lopes LVA; Peixoto LR; Silva KAD; Ortiga-Carvalho TM; Tafuri A; Vago AR; Bloise E
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
